Swiss National Bank’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $5.34M | Sell |
|
|||||
|
2023
Q1 | $5.29M | Sell |
|
|||||
|
2022
Q4 | $2.46M | Buy |
|
|||||
|
2022
Q3 | $1.59M | Hold |
|
|||||
|
2022
Q2 | $1.92M | Hold |
|
|||||
|
2022
Q1 | $2.07M | Buy |
|
|||||
|
2021
Q4 | $1.55M | Hold |
|
|||||
|
2021
Q3 | $5.93M | Buy |
|
|||||
|
2021
Q2 | $8.24M | Buy |
|
|||||
|
2021
Q1 | $5.58M | Buy |
|
|||||
|
2020
Q4 | $6.79M | Buy |
|
|||||
|
2020
Q3 | $5.29M | Buy |
|
|||||
|
2020
Q2 | $8.27M | Buy |
|
|||||
|
2020
Q1 | $6.08M | Buy |
|
|||||
|
2019
Q4 | $7.67M | Buy |
|
|||||
|
2019
Q3 | $2.95M | Buy |
|
|||||
|
2019
Q2 | $3.38M | Buy |
|
|||||
|
2019
Q1 | $2.99M | Buy |
|
|||||
|
2018
Q4 | $1.89M | Buy |
|
|||||
|
2018
Q3 | $2.71M | Buy |
|
|||||
|
2018
Q2 | $906K | Buy |
|
|||||
|
2018
Q1 | $408K | Hold |
|
|||||
|
2017
Q4 | $564K | Hold |
|
|||||
|
2017
Q3 | $619K | Buy |
|
|||||
|
2017
Q2 | $440K | Buy |
|